SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period

LANCET RHEUMATOLOGY

ELSEVIER

1. ZonMw
2. ZonMw (the Netherlands Organization for Health Research and Development)
3. Prinses Beatrix Spierfonds
4. UCB Pharma
5. CSl Behring
6. Reade Foundation